M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule

Summary

This is a Phase I study consisting of 2 parts: Part 1 aims to investigate the relative bioavailability of tablet formulation (test treatment) and Powder in capsule (PiC) formulation (reference treatment) of M7583 under fasted conditions. The aim of Part 2 is to determine and compare the single dose Pharmacokinetic (PK) profile of M7583 tablet under fasted and fed conditions to assess the food effect.

Timeline

Start

2017-10-09

Primary completion

2017-12-06

Completion

2017-12-06

Drugs

Indications

No indication recorded.